CMH :: Clinical and Molecular Hepatology

Position statement on the use of Tenofovir Alafenamide for the treatment of chronic Hepatitis B Virus infection in Africa

Edward John Gane, Allah Kouadio Emile, Onyekwere Charles Asabamaka, Mongo Onkouo, Oudou Njoya, Okon Anassi Jean Baptiste, SOMDA Küssome Paulin, Sombie Arsene Roger, Tadesse T Mekonen

Gastroenterology & Hepatology: Open Access.2021; 11(2): 57. CrossRef

An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia

Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, K

Journal of Gastroenterology.2020; 55(9): 811. CrossRef

ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens

Katherine E. Squires, Douglas L. Mayers, Gregory R. Bluemling, Alexander A. Kolykhalov, David B. Guthrie, Prabhakar Reddy, Debbie G. Mitchell, Manohar T. Saindane, Zachary M. Sticher, Vindhya Edpuganti, Abel De La Rosa

Antimicrobial Agents and Chemotherapy.2020;[Epub] CrossRef

Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM

Advances in Difference Equations.2020;[Epub] CrossRef

The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria

Dong Hyun Sinn, Sung Eun Kim, Beom Kyung Kim, Ji Hoon Kim, Moon Seok Choi

Journal of Viral Hepatitis.2019; 26(12): 1465. CrossRef

Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies

Baxter Hepburn Kachingwe, Yow-Shieng Uang, Tsurng-Juhn Huang, Li-Hsuan Wang, Shwu-Jiuan Lin

Journal of Food and Drug Analysis.2018; 26(1): 401. CrossRef

Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5′-UTR of TRIM22

Keo-Heun Lim, Eun-Sook Park, Doo Hyun Kim, Kyung Cho Cho, Kwang Pyo Kim, Yong Kwang Park, Sung Hyun Ahn, Seung Hwa Park, Kee-Hwan Kim, Chang Wook Kim, Hong Seok Kang, Ah Ram Lee, Soree Park, Heewoo Sim, Juhee Won, Kieun Seok, Jueng Soo You, Jeong-Hoon Lee

Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial

H. J. Yim, I. H. Kim, S. J. Suh, Y. K. Jung, J. H. Kim, Y. S. Seo, J. E. Yeon, C. W. Kim, S. Y. Kwon, S. H. Park, M. S. Lee, S. H. Um, K. S. Byun

Journal of Viral Hepatitis.2018; 25(11): 1321. CrossRef

Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapy

Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang‐Hyub Han

Journal of Medical Virology.2017; 89(1): 85. CrossRef

Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir

Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Seung Up Kim

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang-Hyub Han

Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues

Wei Liu, Hongxuan Song, Qian Chen, Chunli Xu, Wenjing Zhang, Yutian Liu, Baoju Wang, Dongping Xu, Mengji Lu, Dongliang Yang, Xin Zheng

Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B

Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn

Clinical Gastroenterology and Hepatology.2016; 14(11): 1647. CrossRef

Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay

Atsuya Yamashita, Yuusuke Fujimoto, Mayumi Tamaki, Andi Setiawan, Tomohisa Tanaka, Kaori Okuyama-Dobashi, Hirotake Kasai, Koichi Watashi, Takaji Wakita, Masaaki Toyama, Masanori Baba, Nicole de Voogd, Shinya Maekawa, Nobuyuki Enomoto, Junichi Tanaka, Kohj

Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics

Expert Review of Proteomics.2015; 12(6): 683. CrossRef

Emerging Challenges in Managing Hepatitis B in HIV Patients

Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José M. Peña, José V. Fernández-Montero, Laura Benítez, Isabella Esposito, Pablo Barreiro

Current HIV/AIDS Reports.2015; 12(3): 344. CrossRef

Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol

World Journal of Gastroenterology.2015; 21(32): 9544. CrossRef